Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Ortho Clinical Diagnostics Holdings plc

Ortho Clinical Diagnostics Holdings plc (OCDX) Stock Overview

Explore Ortho Clinical Diagnostics Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

OCDX●NASDAQ
HealthcareMedical - Diagnostics & Research
$17.63
$0.16(0.92%)
U.S. Market opens in 59h 21m

Ortho Clinical Diagnostics Holdings plc (OCDX)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-80.14
EPS (TTM)$-0.42
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$19.17
3 Months$17.88
1 Year Target$17.31

OCDX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Ortho Clinical Diagnostics Holdings plc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OCDX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $17.31 for the NASDAQ listing.

Key metrics behind Ortho Clinical Diagnostics Holdings plc's NASDAQ-traded stock include a P/E ratio of -80.14 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of OCDX on the NASDAQ.

Price Performance (NASDAQ: OCDX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-0.56%
5-Year Change
9.50%
All-Time (Max) Change
9.50%

Contact Information

https://www.quidelortho.com
908 218 8000
1001 Route 202, Raritan, NJ, 08869

Company Facts

48,000 Employees
IPO DateJan 28, 2021
CountryUS

Frequently Asked Questions